Biopharmaceutical Corporate Business Development Lead

Immix Biopharma (Nasdaq: IMMX); Los Angeles (CA); On-site; USD 180,000 - 240,000; Full time

Job summary

Immix Biopharma, Inc. seeks a Biopharma Corporate Business Development Lead to build and manage strategic partnerships with pharmaceutical and biotech companies. You will identify opportunities, develop financial analyses, and present insights to leadership to drive value.

You will lead external liaison efforts, attend industry conferences, and monitor competitive dynamics to align with ImmixBio’s partnering objectives and therapeutic area interests.

Qualifications

• Bachelor’s degree or higher in biology, finance or related field.
• Established track record of successful strategic transactions in biopharma/pharmaceuticals.
• Strong knowledge of biotechnology/pharmaceutical industry, drug discovery and development.
• Excellent verbal and written communication, and relationship management skills.

Responsibilities

• Establish and maintain relationships with pharma/biotech companies to identify strategic opportunities.
• Source, screen and track business opportunities aligned with corporate goals.

Skills

Biopharma knowledge

Strategic transactions

Financial modeling

Relationship management

Executive presentations

FDA regulations

Market analysis

Cross-functional collaboration

Industry networking

Problem solving

Education

Bachelor’s degree in biology/finance

Tools

Excel modeling

Job description

Biopharmaceutical Corporate Business Development Lead

Immix Biopharna, Inc (NASDAQ:IMMX)

Our 3 Core Values

• Integrity
• Initiative

What You'll Do

• Establish and maintain strong relationships with pharmaceutical and biotech companies; identify potential strategic corporate development and business partners
• Source, screen and track business opportunities that are aligned with corporate goals and objectives by interacting with biotech, and pharma counterparts
• Lead information research and provide robust analytic and business evaluation support of corporate and business development opportunities, potential company strategies, and key business initiatives
• Develop and present robust financial models and market analyses to value projects
• Visible external liaison in the scientific and biotech communities to raise awareness of company’s partnering objectives and capabilities
• Attend strategic partnering and industry conferences related to therapeutic area of interest
• Monitor and advise the Company’s leadership on competitive intelligence and relevant developments in key indications and therapeutic areas of interest

Skills and Experience We Look For

• Bachelor’s degree or higher in biology, finance or related field with 5-10 years’ biopharma/pharmaceutical experience
• Established track record of successful strategic transactions in the biopharmaceutical industry
• Strong knowledge of biotechnology/pharmaceutical industry, drug discovery and development
• Excellent verbal and written communication skills, strong relationship management skills and strategic thinking
• Proven experience successfully supporting the scientific and business evaluation of technologies, assets, or companies in the biotechnology/pharmaceutical industry
• Demonstrated understanding of pharmaceutical product lifecycle management including drug development, FDA regulations, and commercialization paths
• Outstanding organizational, analytical, interpersonal and communication skills
• Adaptability, flexibility, and willingness to work in a changing environment
• Experience with financial analysis and/ or valuation of biopharmaceutical products and companies and advanced excel/modeling skills required
• A collaborative nature with the knowledge and understanding of the role and importance of working cross-functionally
• Self-starter, highly motivated, results-driven individual; ability to creatively solve problems
• Process-minded with the ability to operate strategically and adapt when appropriate to execute on defined goals in a timely manner
• Experience preparing and delivering presentations to senior management
• Familiarity with biopharma / pharmaceutical portfolio strategy and competitive dynamics

About Immix Biopharma, Inc.

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a global leader in AL Amyloidosis. AL Amyloidosis is a devastating disease where the immune system, that’s supposed to protect, instead produces toxic light chains, clogging up the heart, kidney and liver, causing organ failure and death. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a proprietary CD3ζ, CD8 hinge and binder “digital filter” designed to filter out non-specific activation. NXC-201 teaches the immune system to recognize and eliminate the source of the toxic light chains. NXC-201 is being evaluated in the U.S. multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT06097832), with a potentially registrational design. NXC-201 has been awarded Breakthrough Therapy Designation (BTD) and Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA.